Stefănescu C, Chossiere L, Rusu V, Meignan M
U.M.F. Gr. T. Popa, Facultatea de Medicină, Dept. Biofizică şi Medicină Nucleară, Iaşi.
Rev Med Chir Soc Med Nat Iasi. 1996 Jul-Dec;100(3-4):165-8.
Scintigraphic imagery was used in breast carcinoma mostly for the bone metastases screening, using 99mTc-MDP. Others radiopharmaceuticals can be used to visualize either the primary tumour or the soft tissues metastases. It's mainly the case of 99mTc-MIBI, and also of some somatostatin analogues, like Octreoscan. This case report of a patient with a T3N1M+ breast adenocarcinoma having different secondary sites represent also a prove of the complementarity of these explorations, which give the possibility of diagnostic and therapeutic evaluation and, in the same time, the possibility of a better understood of the metastasizing mechanism.
闪烁成像主要用于乳腺癌的骨转移筛查，使用的是99mTc-MDP。其他放射性药物可用于显示原发性肿瘤或软组织转移灶。主要是99mTc-MIBI的情况，还有一些生长抑素类似物，如奥曲肽扫描。本病例报告了一名患有T3N1M+乳腺腺癌且有不同继发部位的患者，这也证明了这些检查的互补性，它们提供了诊断和治疗评估的可能性，同时也有助于更好地理解转移机制。
